Display options
Cite
Mullard A. FDA outlines steps for individualized drug development. Nat Rev Drug Discov. 2021;20(2):91doi: 10.1038/d41573-021-00009-7.
Mullard, A. (2021). FDA outlines steps for individualized drug development. Nature reviews. Drug discovery, 20(2), 91. https://doi.org/10.1038/d41573-021-00009-7
Mullard, Asher. "FDA outlines steps for individualized drug development." Nature reviews. Drug discovery vol. 20,2 (2021): 91. doi: https://doi.org/10.1038/d41573-021-00009-7
Mullard A. FDA outlines steps for individualized drug development. Nat Rev Drug Discov. 2021 Feb;20(2):91. doi: 10.1038/d41573-021-00009-7. PMID: 33441996.
Copy Download .nbib Format: NLM
Share it on

Nat Rev Drug Discov. 2021 Feb;20(2):91. doi: 10.1038/d41573-021-00009-7.

FDA outlines steps for individualized drug development.

Nature reviews. Drug discovery

Asher Mullard

PMID: 33441996 DOI: 10.1038/d41573-021-00009-7

[No abstract available.]

Publication Types